August 29, 2018
Sempre Health, a San Francisco-based company that uses monetary incentives and pricing to encourage healthy behaviors, announced today that it has obtained $8 million in Series A financing. Rethink Impact was the lead investor, and was joined by Social Capital and other unnamed backers.
“We are incredibly excited to invest in Sempre Health as it uses its core technology to tackle the nearly $300...
April 18, 2018
Novo Nordisk and San Francisco-based Sempre Health have announced their collaboration on a pilot program that will offer diabetes medications through the latter company’s monetary incentive and SMS-driven prescription refill platform. The partnership is hoping to engage 10,000 diabetes patients on Sempre’s platform within 2018.
“Looking at some of the metrics that Sempre has been able to provide...
July 27, 2017
Sempre Health, a San Francisco-based company that uses monetary incentives to encourage timely prescription refills, officially launched last week with $2.5 million in funding from Social Capital Partnership, quietly raised last year.
Using SMS, Sempre works with pharmacy benefit managers to inform patients about discounts on their prescriptions — and then those discounts change to incentivize...